Sangamo Therapeutics Revenue, Growth & Competitor Profile

DBA SANGAMO BIOSCIENCES INC

Company Profile & Annual Report for Sangamo Therapeutics

Access the complete profile.

Sangamo Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	501 Canal Blvd. Suite A100 Richmond, CA 94804

Sangamo Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sangamo Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Sangamo Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Sangamo Therapeutics is a publicly traded company on NMS using the ticker symbol SGMO. Detailed information on company financials and operating reports can be found here: NMS: SGMO

Sangamo Therapeutics Annual Revenue and Growth Rate

Sangamo Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sangamo Therapeutics's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Sangamo Therapeutics is developing and marketing. Sangamo Therapeutics doesn't have any recent trademark applications, indicating Sangamo Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SIFTER Providing gene therapy services, namely, screening libraries of adeno-associated viruses (AAVs) to target specific cell types	03/08/2022
SANGAMO THERAPEUTICS Biochemicals, namely, engineered proteins for the regulation of human, animal, plant, viral and microbial genes for clinical and medical laboratory use in human and animal therapeutics, DNA diagnostics and bioinformatics	11/30/2016
PIONEERING GENETIC CURES Biologicals, namely, engineered cells for the production of human, animal, plant, viral, microbial and synthetic proteins for clinical use and for use in human and animal therapeutics	08/11/2016

See all trademarks and details in the Full Report.

Market Share of Sangamo Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sangamo Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Sangamo Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SANGAMO THERAPEUTICS	Richmond, CA	100
X-THERMA	San Pablo, CA	7
PROMAB BIOTECHNOLOGIES	Richmond, CA	6
MIRRORCLE TECHNOLOGIES	Richmond, CA	3
GAMMA REALITY	Richmond, CA	3
STAIDSON BIOPHARMA	San Pablo, CA	2

Future Competition: Sangamo Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Sangamo Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)